No significant differences in survival were found at 1 or 2 years among veterans with vs without rheumatoid arthritis receiving ICIs as cancer treatment. Patients with rheumatoid arthritis (RA) who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback